Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future

Authors: Laura M. Spring, Seth A. Wander, Fabrice André, Beverly Moy, Nicholas C. Turner, Aditya Bardia - The Lancet 2020 cited by 466